These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1669563)

  • 1. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
    Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
    J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
    Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
    J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
    Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
    Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.
    Asturias JA; Ferrer A; Arilla MC; Andreu C; Madariaga B; Martínez A
    Clin Exp Immunol; 2007 Mar; 147(3):491-6. PubMed ID: 17302898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Level of specific IgE and IgG in blood serum of patients with hay fever after several cycles of desensitization with pollinex vaccine].
    Szymański W
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):412-4. PubMed ID: 1669077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis.
    Juniper EF; Kline PA; Ramsdale EH; Hargreave FE
    J Allergy Clin Immunol; 1990 Mar; 85(3):606-11. PubMed ID: 2107241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
    Tari MG; Mancino M; Ghezzi E; Frank E; Cromwell O
    Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid].
    Mühlethaler K; Wüthrich B; Peeters AG; Terki N; Girard JP; Frank E
    Schweiz Rundsch Med Prax; 1990 Apr; 79(14):430-6. PubMed ID: 2188335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating immune complexes in patients treated with Pollinex vaccine].
    Wrzyszcz M; Małolepszy J; Krasnowska M; Liebhart E; Medrala W; Kopeć W
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):737-9. PubMed ID: 2128120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.
    Panzani RC; Ariano R; Augeri G
    Allergol Immunopathol (Madr); 1996; 24(6):263-8. PubMed ID: 9010562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
    García-Sellés J; Pascual A; Funes E; Pagán JA; López JD; Negro JM; Hernández J
    Allergol Immunopathol (Madr); 2003; 31(2):63-9. PubMed ID: 12646120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG and IgE antibody response following Pollinex-R immunotherapy.
    Ko HS; Chen SJ; Jaworska E
    Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
    Pfaar O; van Twuijver E; Hecker H; Boot JD; van Ree R; Klimek L
    Int Arch Allergy Immunol; 2013; 160(4):420-4. PubMed ID: 23183541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.